Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marcelo V,Negrao

第一单位： Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

作者： Marcelo V,Negrao ^[1] ; Vassiliki A,Papadimitrakopoulou ^[1] ; Andrew C,Price ^[2] ; Alda L,Tam ^[3] ; Muhammad,Furqan ^[4] ; Sandeep T,Laroia ^[5] ; Erminia,Massarelli ^[6] ; Jose,Pacheco ^[7] ; John V,Heymach ^[1] ; Anne S,Tsao ^[1] ; Gary V,Walker ^[2] ; Lalit,Vora ^[8] ; David,Mauro ^[9] ; Heather,Kelley ^[9] ; James E,Wooldridge ^[9] ; Arthur M,Krieg ^[9] ; Jiaxin,Niu ^[10]

作者单位： Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] Department of Radiology, Banner MD Anderson Cancer Center, Gilbert, Arizona. ^[2] Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[3] Department of Internal Medicine, Carver College of Medicine, University of Iowa Health Care, Iowa City, Iowa. ^[4] Department of Radiology, Division of Vascular and Interventional Radiology, Carver College of Medicine, University of Iowa Health Care, Iowa City, Iowa. ^[5] Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California. ^[6] Department of Medicine-Medical Oncology, University of Colorado, Aurora, Colorado. ^[7] Department of Diagnostic Radiology, City of Hope, Duarte, California. ^[8] Checkmate Pharmaceuticals, Cambridge, Massachusetts. ^[9] Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona. ^[10]

关键词 Atezolizumab NSCLC Radiation TLR9 agonist Vidutolimod

DOI 10.1016/j.jtocrr.2022.100423

PMID 36925644

发布时间 2024-09-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JTO clinical and research reports

2023年4卷3期

100423页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.

JTO clinical and research reports

相似文献

JTO clinical and research reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.

JTO clinical and research reports

相似文献

JTO clinical and research reports

相关期刊

检索历史清除